<DOC>
	<DOCNO>NCT00526487</DOCNO>
	<brief_summary>The purpose study evaluate safety effectiveness performance Zenith® Dissection Endovascular System treatment aortic dissection involve descend thoracic aorta .</brief_summary>
	<brief_title>Clinical Study Assess Safety Effectiveness Zenith® Dissection Endovascular System Patients With Aortic Dissection</brief_title>
	<detailed_description>The Zenith® Thoracic Dissection Study clinical trial study safety effectiveness Zenith® Dissection Endovascular System treatment dissection ( length-wise tear ) descend thoracic aorta . The Zenith® Dissection Endovascular System comprise Zenith TX2® TAA Endovascular Graft Zenith® Dissection Endovascular Stent . Instead make large incision chest , physician make small incision near hip insert , guide graft dissection stent place aorta .</detailed_description>
	<criteria>Branch vessel obstruction/compromise Periaortic effusion/hematoma Resistant hypertension Persistent pain/symptoms Transaortic growth great equal 5 mm within 3 month ( transaortic diameter great equal 40 mm ) Age le 18 year Frank rupture Diagnosed suspected congenital degenerative connective tissue disease Systemic infection Untreatable reaction contrast Surgical/endovascular AAA repair within 30 day Previous placement thoracic endovascular graft Prior repair descend thoracic aorta Interventional/open procedure within 30 day Onset symptom &gt; 3 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Thoracic Dissection</keyword>
	<keyword>Dissection</keyword>
	<keyword>Endovascular</keyword>
</DOC>